West Pharmaceutical Services Inc.
Cindy Reiss-Clark Departs as Senior Vice President and Chief Commercial Officer at West Pharmaceutical Services
Summary
On March 7, 2025, Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer of West Pharmaceutical Services, Inc., departed the company. As part of her departure, she is entitled to severance benefits including one-year of salary continuation, continuation of welfare benefits, a 2025 payment of her pro-rated Annual Incentive Plan target, and outplacement services. These benefits are contingent upon her execution of a Separation Agreement and Release. The agreement includes a release of claims, noncompetition and nonsolicitation covenants, and a nondisparagement provision. A copy of the agreement is furnished as an exhibit to this Form 8-K.
Profitelligence Alerts
Get alerts for WST
Be first to know when West Pharmaceutical Services Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.
Official SEC Documents
Advertisement